Alpine Immune Sciences, Inc. - stock earnings
ALPN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -11.7 million USD | 10.0 million USD |
| 2023Q2 | -13.2 million USD | 8.6 million USD |
| 2023Q1 | -11.0 million USD | 9.4 million USD |
| 2022Q4 | -18.9 million USD | 2.8 million USD |
| 2022Q3 | -12.7 million USD | 8.4 million USD |
| 2022Q2 | -18.1 million USD | 5.3 million USD |
| 2022Q1 | -7.5 million USD | 13.6 million USD |
| 2021Q4 | -15.2 million USD | 4.5 million USD |
| 2021Q3 | -13.5 million USD | 8.5 million USD |
| 2021Q2 | -11.0 million USD | 7.2 million USD |
| 2021Q1 | -10.6 million USD | 3.2 million USD |
| 2020Q4 | -6.3 million USD | 5.6 million USD |
| 2020Q3 | -6.1 million USD | 1.9 million USD |
| 2020Q2 | -9.9 million USD | 688000 USD |
| 2020Q1 | -5.5 million USD | 1.1 million USD |
| 2019Q4 | -6.1 million USD | 884000 USD |
| 2019Q3 | -11.5 million USD | 289000 USD |
| 2019Q2 | -11.9 million USD | 567000 USD |
| 2019Q1 | -12.4 million USD | ? USD |
| 2018Q4 | -11.1 million USD | 705000 USD |
| 2018Q3 | -12.1 million USD | 390000 USD |
| 2018Q2 | -7.9 million USD | 390000 USD |
| 2018Q1 | -5.3 million USD | 315000 USD |
| 2017Q4 | -4.3 million USD | 128000 USD |
| 2017Q3 | 2.1 million USD | 128000 USD |
| 2017Q2 | -3.7 million USD | 738000 USD |
| 2017Q1 | -8.9 million USD | 737000 USD |
| 2016Q4 | -7.7 million USD | 3.0 million USD |
| 2016Q3 | -7.4 million USD | ? USD |
| 2016Q2 | -8.5 million USD | ? USD |
| 2016Q1 | -7.8 million USD | ? USD |
| 2015Q4 | -6.6 million USD | ? USD |
| 2015Q3 | -6.1 million USD | ? USD |
| 2015Q2 | -5.9 million USD | ? USD |
| 2015Q1 | -4.3 million USD | ? USD |
| 2014Q4 | -3.5 million USD | ? USD |
| 2014Q3 | -3.0 million USD | ? USD |
| 2014Q2 | -4.2 million USD | ? USD |
| 2014Q1 | -4.4 million USD | ? USD |
ALPN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -57.0 million USD | 30.8 million USD |
| 2022 | -57.8 million USD | 30.1 million USD |
| 2021 | -50.3 million USD | 23.4 million USD |
| 2020 | -27.9 million USD | 9.3 million USD |
| 2019 | -42.5 million USD | 1.7 million USD |
| 2018 | -36.5 million USD | 705000 USD |
| 2017 | -7.8 million USD | 1.7 million USD |
| 2016 | -31.5 million USD | ? USD |
| 2015 | -22.8 million USD | 492000 USD |
| 2014 | -15.0 million USD | ? USD |
| 2013 | -16.2 million USD | ? USD |
| 2012 | -9.6 million USD | ? USD |
ALPN
Price: $64.56
52 week price:
Earnings Per Share: -0.64 USD
P/E Ratio: -22.30
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 35394
Ebitda: 2.3 millionMarket Capitalization: 2.6 billion